Mu‐Hsien Yu

1.9k citations
43 papers · 1.4k indexed · h-index 21
Topics
Cervical Cancer and HPV Research (9 papers)Epigenetics and DNA Methylation (7 papers)Ovarian cancer diagnosis and treatment (7 papers)
Partner nations
TaiwanUnited StatesIndia

In The Last Decade

Mu‐Hsien Yu

43 papers receiving 1.3k citations

Peers

Mu‐Hsien Yu
Comparison fields: 5 of 90
  • Molecular Biology 813
  • Cancer Research 323
  • Epidemiology 298
  • Reproductive Medicine 255
  • Oncology 236
Replace Beihua Kong with:
Beihua Kong China
Rhona J. McVey United Kingdom
Tamara Kalir United States
Hanoch Levavi Israel
Jesus Paula Carvalho Brazil
Ting-Chang Chang Taiwan
Takashi Miyatake Japan
Graziella M. Abu‐Jawdeh United States
Katsumi Tsukazaki Japan
Amal Kanbour‐Shakir United States
Mu‐Hsien Yu relative to Beihua Kong China Beihua Kong's profile →
Citations per field
00.5×1.5×
Beihua Kong · 1×
Citations per year

Countries citing papers authored by Mu‐Hsien Yu

Since Specialization
Citations

This map shows the geographic impact of Mu‐Hsien Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu‐Hsien Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu‐Hsien Yu more than expected).

Fields of papers citing papers by Mu‐Hsien Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu‐Hsien Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu‐Hsien Yu. The network helps show where Mu‐Hsien Yu may publish in the future.

Co-authorship network of co-authors of Mu‐Hsien Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Mu‐Hsien Yu. A scholar is included among the top collaborators of Mu‐Hsien Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu‐Hsien Yu. Mu‐Hsien Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 39
3 31
4 105
5 3
6 20
7 91
8 154
9 5
10 11
11 41
12 36
13 34
14 4
15 6
16 9
17 2
18 84
19 20
20 8

About Mu‐Hsien Yu

Mu‐Hsien Yu is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 43 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (9 papers), Epigenetics and DNA Methylation (7 papers) and Ovarian cancer diagnosis and treatment (7 papers). The work is most often cited by research in Reproductive Medicine (255 citations), Obstetrics and Gynecology (221 citations) and Cancer Research (323 citations). Mu‐Hsien Yu has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Hung‐Cheng Lai, Cheng‐Chang Chang, Tang‐Yuan Chu, Ya‐Wen Lin, Rui Huang, Huey‐Kang Sytwu, Yu-Ping Liao, Hui-Chen Wang, Yu‐Lueng Shih and Ya‐Wen Lin. Their work appears in journals such as Scientific Reports, Human Molecular Genetics and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026